
Scientists are investigating whether gut microbiome changes and altered stool transit help explain rising colorectal cancer in younger adults. The ACS endorsement of a blood-based screening option provides an additional clinical tool to detect disease earlier while research continues into biological causes; however, blood tests complement rather than replace diagnostic procedures.
Click a connection line between nodes to view confidence and evidence.